Search results
Results from the WOW.Com Content Network
Pages in category "Drugs developed by Genentech" The following 102 pages are in this category, out of 102 total. This list may not reflect recent changes. A.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, operating as an [6] independent subsidiary of the multinational holding company, the Roche Group. It is incorporated in Delaware. Genentech Research and Early Development operates as an independent center within Roche. [7]
From 2017 to 2018, he was the CEO of Genentech. [6] While at Genentech, he developed its immunology and ophthalmology divisions, managed the sales of Rituxan, Raptiva, and Xolair, and directed Roche's late-stage portfolio committee for nearly four years, where he was responsible for determining late-stage clinical trial advancements. [6]
Genentech. 7,115 1,456 6 Insulin glargine: Lantus Biologic Diabetes mellitus: Sanofi: 7,029 51 7 ... List of drugs; Lists about the pharmaceutical industry; References
Drugs developed by Genentech (102 P) P. Genentech people (21 P) Pages in category "Genentech" The following 2 pages are in this category, out of 2 total.
Rank Year Purchaser Target Value (in billions USD) Value (adjusted for inflation) 1 2015 Pfizer: Allergan, plc: 160 206 In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation).
Pages in category "Health care companies based in California" The following 107 pages are in this category, out of 107 total. This list may not reflect recent changes .
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.